| |
|
|
|
|
|
The IL ACL 100 is a fully automated, clot-end point analyzer, putting some of the world's most advanced coagulation technology within reach of small laboratories or laboratories interested only in clot-endpoint analysis
|
Company:
Date:
December 18, 2008
|
|
|
|
|
|
|
|
|
|
The ACL 1000 is a fully automated, clot-end point analyzer, putting some of the world's most advanced coagulation technology within reach of small laboratories or laboratories interested only in clot-endpoint analysis
|
Company:
Date:
December 18, 2008
|
|
|
|
|
|
|
|
|
|
The ACL 7000 coagulation analyzer is the right choice for any laboratory that needs a full range of testing capabilities in a cost-effective system. You'll have access to a broad test menu including D-Dimer, Heparin and APCR-Leiden. Plus, you'll benefit from an easy-to-use, automated system that provides consistently reliable results.
|
Company:
Date:
December 18, 2008
|
|
|
|
|
|
|
|
|
|
A commonly used laboratory test to confirm the existence of myocardial damage is the measurement of a small fraction of the creatine kinase (CK) enzyme, mass CK-MB (mCK-MB). mCK-MB will not normally be elevated until 6 to 8 hours after the onset of MI.1
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
For patients in need of an early diagnosis, a rapidly appearing biochemical marker (such as Myoglobin) plus a specific marker that rises later (e.g., cTnI) are recommended.1 In addition, Myoglobin has an excellent negative predictive value in the evaluation of patients with acute chest pain.2-6
Myoglobin, a low molecular weight heme protein found in cardiac and skeletal muscle, is valuable in the early evaluation of chest pain patients. It may appear in the blood in abnormal levels as early as 1 to 3 hours after onset of myocardial ischemia. While Myoglobin is not specific to cardiac muscle,
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
Enhancing the Siemens Healthcare Diagnostics leadership position in cardiac markers and enriching an already comprehensive cardiac disease state panel that includes cardiac troponin I, hsCRP and myoglobin, the NT-proBNP assay is used to risk stratify patients with Acute Coronary Syndromes (ACS) and Congestive Heart Failure (CHF), and is also an aid in diagnosing CHF. Now you have even more of a reason to select Siemens for your total cardiac solution.
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
Running STAT ßhCG from whole blood allows for more expeditious clinical decision-making and provision of appropriate care. It eliminates the need for duplicate, confirmatory testing and rapidly provides information to address potential pregnancy complications.
ßhCG on the Stratus® CS STAT Fluorometric Analyzer provides rapid, quantitative results for the early detection of pregnancy from a whole blood sample in as little as 14 minutes.
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
The Triage® Cardiac System is a hand-held, point-of-care diagnostic cardiac marker test capable of detecting an acute myocardial infarction (AMI), commonly known as a heart attack, in about 15 minutes. The Triage® Cardiac Panel provides a rapid, quantitative screen for three cardiac markers, creatine kinase-MB (CK-MB), myoglobin and troponin I, which are released in the blood when an AMI occurs. Developed by Biosite Incorporated, the Triage® Cardiac System consists of two components: the disposable Triage® Cardiac Panel and the portable Triage® Meter, the size of a business telephone, that dis
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
ESA Biosciences, Inc. (a Magellan Biosciences Company) and RNA Medical have recently partnered in the distribution and sale of the LeadCare® II Analyzer, with RNA Medical focusing on the hospital point of care setting. The world’s only CLIA-waived blood-lead analyzer, LeadCare II improves clinical outcomes and is ideal for the physicians’ office, health clinic, Point of Care Testing or outreach-screening program.
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
Breath offers a 13C-urea breath test solution for Helicobacter pylori in-office testing. With the BreathID Hp FasTest, patient testing time is around 10 minutes.
|
Company:
Date:
February 15, 2010
|
|
|
|
|
|